Hensel, Charles H. http://orcid.org/0000-0002-2932-1807
Vanzo, Rena J.
Martin, Megan M.
Ling, Ling
Aliaga, Solange M.
Bui, Minh
Francis, David I.
Twede, Hope
Field, Michael H.
Morison, Jonathon W.
Amor, David J.
Godler, David E.
Article History
Received: 28 November 2018
Accepted: 30 September 2019
First Online: 25 October 2019
Competing interests
: David Eugeny Godler is named as an inventor on patent applications [PCT/AU2010/000169, PCT/AU2011/001024 and PCT/AU2014/000044] related to the technology described in this article. Lineagen Inc. currently utilizes AmplideX PCR (Asuragen) and AmplideX mPCR (Asuragen) as a commercial genetic testing offering. The other authors declare that they have no competing interests.